Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001232140 | SCV001404686 | uncertain significance | Cohen syndrome | 2022-11-01 | criteria provided, single submitter | clinical testing | This variant is present in population databases (no rsID available, gnomAD 0.01%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt VPS13B protein function. ClinVar contains an entry for this variant (Variation ID: 958890). This variant has not been reported in the literature in individuals affected with VPS13B-related conditions. This sequence change replaces isoleucine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 3760 of the VPS13B protein (p.Ile3760Met). |
New York Genome Center | RCV001232140 | SCV003925191 | uncertain significance | Cohen syndrome | 2022-07-01 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001232140 | SCV002082791 | uncertain significance | Cohen syndrome | 2020-04-30 | no assertion criteria provided | clinical testing |